Lidocaine / tetracaine topical Pregnancy and Breastfeeding Warnings
Brand names: Pliaglis, S-Caine Peel, Synera
Medically reviewed by Drugs.com. Last updated on Mar 21, 2024.
Lidocaine / tetracaine topical Pregnancy Warnings
Lidocaine-tetracaine topical has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetotoxicity following administration of up to 6.6 times the human dose. There are no controlled data in human pregnancy. Lidocaine-tetracaine topical is only recommended for use during pregnancy when benefit outweighs risk.
Lidocaine / tetracaine topical Breastfeeding Warnings
Lidocaine is excreted into human milk. There are no data on the excretion of tetracaine into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering lidocaine-tetracaine topical to nursing women.
See also
References for pregnancy information
- (2005) "Product Information. Synera (lidocaine-tetracaine topical)." Ferndale Laboratories Inc
References for breastfeeding information
- (2005) "Product Information. Synera (lidocaine-tetracaine topical)." Ferndale Laboratories Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
